Ensign Peak Advisors, Inc

Position in ALXO — Alx Oncology Holdings Inc

CIK 1454984 SALT LAKE CITY, UT

Position in ALXO

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$1,905,852

+$1,894,931 QoQ

Shares Held

950,550

+70311.1% QoQ

Ownership

0.706%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#19

of 68 holders

Holding Since

Dec 2020

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Ensign Peak Advisors, Inc holds $1,158,535,687 across 116 Biotechnology names. ALXO ranks #67 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	215,165	$96,079,779
2	INSM	INSMED Inc	499,756	$81,720,101
3	ABVX	Abivax S.A.	631,838	$70,355,161
4	BBIO	BridgeBio Pharma, Inc.	836,552	$62,122,351
5	ARGX	Argenx SE	71,598	$52,284,439
6	RPRX	Royalty Pharma plc	932,650	$44,739,220
7	PTCT	Ptc Therapeutics, Inc.	582,318	$39,673,325
8	SRRK	Scholar Rock Holding Corp	717,253	$35,260,157

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,905,852	950,550	+70311.1%	Shares	Sole	2026-05-13
2022-06-30	$10,921	1,350	-98.9%	Shares	Sole	2022-08-12
2022-03-31	$2,153,600	127,432	0.0%	Shares	Sole	2022-05-16
2021-12-31	$2,738,513	127,432	-63.1%	Shares	Sole	2022-02-11
2021-09-30	$25,517,448	345,484	-8.3%	Shares	Sole	2021-11-12
2021-06-30	$20,606,978	376,865	+12.1%	Shares	Sole	2021-08-13
2021-03-31	$24,798,688	336,299	+1143.5%	Shares	Sole	2021-05-12
2020-12-31	$2,331,192	27,044	—	Shares	Sole	2021-02-12
No filing history on record for this holder in this stock.